Skip to Main Content

Paper Details

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.
Oncotarget
20
2018
ALK, ALK positive lung cancer, ALK+, ALK+ NSCLC, ALK+ cells, MYC, MYCBP, anaplastic lymphoma, anaplastic lymphoma kinase, anaplastic lymphoma kinase (ALK) oncogene, c-MYC, c-MYC target genes, crizotinib, lung cancers, oncogene, oncogene-driven cancer, patients, tumor
Author NameAffiliation
Katherine R SingletonUniversity of Colorado Cancer Center
Aik Choon TanUniversity of Colorado Cancer Center
Aik Choon TanUniversity of Colorado Cancer Center
James DeGregoriUniversity of Colorado Cancer Center
  • 1 - 4

Datasets

Release 1.2